—Mkt Cap: —P/E: —
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value282.58B $
Revenue (TTM)61.37B $
Gross Profit48.11B $
Net Income (TTM)10.22B $
Revenue/Share39.59 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees96.1K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)—
P/E (Forward)14.48
PEG1.42
EV/EBITDA14.20
EV/Revenue4.60
P/S4.16
P/B5.07
EPS (TTM)6.68
EPS (Forward)11.36
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin81.90%
Oper. Margin23.46%
EBITDA Margin32.44%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth6.40%
Earnings Growth2.50%
Cash Flow & Leverage
Operating CF14.57B $
CapEx (TTM)5.91B $
FCF Margin7.99%
FCF Yield—
Net Debt27.38B $
Net Debt/EBITDA1.38
Balance Sheet
Debt/Equity0.60
Current Ratio0.89
Quick Ratio0.66
Book Value/Sh32.43 USD
Cash/Share3.203 USD
Dividends
Fwd Div Rate3.200 USD
Trail. Div Rate3.230 USD
Div. Yield1.94%
5Y Avg Yield2.09%
Payout Ratio47.41%
Ex-Div DateAug 7, 2026
Pay DateSep 8, 2026
Splits
Last Split1:2
Split DateFeb 2, 2026
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)213.99 USD
Target Range184.00 USD – 240.00 USD
# Analysts10
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions65.37%
Short Interest
Short Ratio0.7d
Short % Float0.12%
Short % Out.0.12%
Shares Short1.84M
Short (prev mo.)1.53M
Technical
SMA 50172.79 USD
SMA 200184.29 USD
Beta0.21
S&P 52W Chg21.00%
Avg Vol (30d)—
Avg Vol (10d)3.42M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—